Ticker Details
Bio-Rad Laboratories, Inc.Class A Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$7.32B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.61 | 1.14%
Avg Daily Range (30 D):	$3.67 | 1.25%
Avg Daily Range (90 D):	$4.15 | 1.35%

Institutional Daily Volume
Avg Daily Volume:	.11M
Avg Daily Volume (30 D):	.23M
Avg Daily Volume (90 D):	.18M

Trade Size
Avg Trade Size (Sh.):	49
Avg Trade Size (Sh.) (30 D):	22
Avg Trade Size (Sh.) (90 D):	22

Institutional Trades
Total Institutional Trades:	4,309
Avg Institutional Trade:	$9.06M
Avg Institutional Trade (30 D):	$8.84M
Avg Institutional Trade (90 D):	$8.5M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$11.29M
Avg Closing Trade (30 D):	$10.06M
Avg Closing Trade (90 D):	$9.41M
Avg Closing Volume:	32.79K

News

Jan 30, 2026 @ 9:59 AM Chromatography Research Report 2026 - Global $13.6... Source: Researchandmarkets.Com

Jan 26, 2026 @ 4:00 PM Microarrays Market Size to Accumulate Around USD 1... Source: Sns Insider

Jan 22, 2026 @ 3:35 AM Next Generation Sequencing Market Size to Worth US... Source: Nova One Advisor

Jan 21, 2026 @ 1:11 PM Qiagen Explores Possible Sale After New Buyer Talk... Source: Vandana Singh

Jan 21, 2026 @ 9:38 AM Antibody Optimization Service (Affinity Maturation... Source: Researchandmarkets.Com

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$27.87		$27.87
Diluted EPS	$27.85		$27.85
Revenue	$2.58B		$2.58B
Gross Profit	$1.34B		$1.34B
Net Income / Loss	$759.9M		$759.9M
Operating Income / Loss	$47.2M		$47.2M
Cost of Revenue	$1.24B		$1.24B
Net Cash Flow	$59.3M		$59.3M
PE Ratio	9.65

Splits
Mar 08, 2002	2:1